Trial Profile
A phase 2a clinical trial to evaluate safety and efficacy of mTORC1 program.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2017
Price :
$35
*
At a glance
- Drugs MTORC1 protein inhibitors (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions; Therapeutic Use
- 21 Apr 2017 New trial record